Nowadays fish pedicures have become a popular form of pedicure where fish eat dead skin off a person’s feat. But a woman in her 20’s from New York approached a doctor when her toenails started becoming abnormal. She told the doctor that she had been having the issue for around 6 months, from the moment she had the fish pedicure. There was no pain but a few breaks in her toenails, due to which the bottom portion of her nails got separated from the upper portion.
Current HIV drugs usually act on enzymes needed by the virus throughout its survival. But no drug targets the outermost layer of the virus named the capsid, which protects the genetic material delivered into the host.
Royal Free London NHS Foundation Trust and Teesside University researchers helped organize a ‘hackathon’ on 4 and 5 July 2018 at Brunel University in London with an aim to develop virtual reality (VR) tools for patients.
Researchers from South Ural State University (SUSU) found that man has been suffering from Hepatitis B since the Bronze Age with the help of viral traces in the genomes of ancient people. To understand how some of the ancient diseases spread and to find out how they might behave in the future, an international collaboration between researchers had been analyzing DNA of the relics of ancient people found in areas from Mongolia to Europe for several years.
Dr. Lionel Piroth and Dr. Marine Jacquier from the Centre Hospitalier Universitaire in Dijon reported in the New England Journal of Medicine, “A 35-year-old French woman presented to the emergency department with weakness, a feeling of electric shocks in both legs, and repeated falls; She reported that the symptoms had been progressing, and she noted that she had had difficulty riding her horse for the preceding three months.”
The US-based RAZOR (Randomised Open versus Robotic Cystectomy) trial revealed that robotic surgery is equally effective as traditional open surgery in order to treat bladder cancer. The study was funded by the National Cancer Institute and the discovery was published in the Lancet.
Ibrutinib plus venetoclax (ABT-199) improves outcomes over standard therapy in patients with mantle-cell lymphoma (MCL) and a poor prognosis reports a new research in the New England Journal of Medicine.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.